TLLPharmaceuticals

Trident Lifeline LtdProfit & Loss Statement

268.35
+5.50%

Trident Lifeline Ltd Profit & Loss Statement (Annual)

Metric20252024202320222021
Tax Effect Of Unusual Items0.000.00-0.03 Cr-0.03 Cr
Tax Rate For Calcs0.230.320.090.30
Normalized EBITDA23.09 Cr10.27 Cr7.62 Cr3.35 Cr
Total Unusual Items0.000.00-0.30 Cr-0.09 Cr
Total Unusual Items Excluding Goodwill0.000.00-0.30 Cr-0.09 Cr
Net Income From Continuing Operation Net Minority Interest11.75 Cr6.34 Cr6.02 Cr3.95 Cr
Reconciled Depreciation5.49 Cr0.97 Cr0.36 Cr0.20 Cr
Reconciled Cost Of Revenue45.55 Cr29.35 Cr22.58 Cr16.87 Cr
EBITDA23.09 Cr10.27 Cr7.32 Cr3.25 Cr
EBIT17.60 Cr9.30 Cr6.95 Cr3.05 Cr
Net Interest Income-3.99 Cr-0.60 Cr0.27 Cr-0.13 Cr
Interest Expense3.99 Cr0.60 Cr0.37 Cr0.07 Cr
Normalized Income11.75 Cr6.34 Cr6.29 Cr4.01 Cr
Net Income From Continuing And Discontinued Operation11.75 Cr6.34 Cr6.02 Cr3.95 Cr
Total Expenses77.60 Cr37.41 Cr25.49 Cr19.17 Cr
Diluted Average Shares1.15 Cr1.15 Cr0.97 Cr1.15 Cr
Basic Average Shares1.15 Cr1.15 Cr0.97 Cr1.15 Cr
Diluted EPS10.225.526.223.43
Basic EPS10.225.526.223.43
Diluted NI Availto Com Stockholders11.75 Cr6.34 Cr6.02 Cr3.95 Cr
Net Income Common Stockholders11.75 Cr6.34 Cr6.02 Cr3.95 Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income11.75 Cr6.34 Cr6.02 Cr3.95 Cr
Minority Interests1.25 Cr0.40 Cr-32000.00
Net Income Including Noncontrolling Interests10.49 Cr5.94 Cr6.02 Cr3.95 Cr
Net Income Continuous Operations10.49 Cr5.94 Cr6.02 Cr3.95 Cr
Tax Provision3.12 Cr2.76 Cr0.56 Cr-0.96 Cr
Pretax Income13.61 Cr8.70 Cr6.58 Cr2.98 Cr
Other Non Operating Income Expenses8.23 Cr2.08 Cr0.20 Cr0.51 Cr
Special Income Charges0.000.00-0.30 Cr-0.09 Cr
Net Non Operating Interest Income Expense-3.99 Cr-0.60 Cr0.27 Cr-0.13 Cr
Interest Expense Non Operating3.99 Cr0.60 Cr0.37 Cr0.07 Cr
Operating Income9.37 Cr7.22 Cr6.21 Cr2.60 Cr
Operating Expense32.04 Cr8.06 Cr2.91 Cr2.30 Cr
Other Operating Expenses14.46 Cr4.69 Cr3.61 Cr70000.00
Depreciation And Amortization In Income Statement5.49 Cr0.97 Cr0.36 Cr0.20 Cr
Depreciation Income Statement5.49 Cr0.97 Cr0.36 Cr0.20 Cr
Gross Profit41.41 Cr15.28 Cr9.12 Cr4.90 Cr
Cost Of Revenue45.55 Cr29.35 Cr22.58 Cr16.87 Cr
Total Revenue86.96 Cr44.63 Cr31.69 Cr21.77 Cr
Operating Revenue86.96 Cr44.63 Cr31.69 Cr21.77 Cr
Interest Income1.46 Cr0.76 Cr0.0014000.00
Rent Expense Supplemental0.33 Cr0.34 Cr0.14 Cr0.13 Cr
Net Income Extraordinary0.000.00
Net Income Discontinuous Operations0.000.000.00
Write Off0.63 Cr0.30 Cr0.01 Cr
Total Other Finance Cost0.08 Cr0.11 Cr0.06 Cr0.02 Cr
Interest Income Non Operating1.46 Cr0.76 Cr0.0014000.00
Research And Development0.04 Cr0.02 Cr0.02 Cr
Selling General And Administration0.91 Cr0.58 Cr0.75 Cr0.70 Cr
Selling And Marketing Expense0.17 Cr0.04 Cr0.08 Cr0.40 Cr
General And Administrative Expense0.75 Cr0.54 Cr0.67 Cr0.30 Cr
Rent And Landing Fees0.33 Cr0.34 Cr0.14 Cr0.13 Cr
Other Special Charges0.30 Cr0.08 Cr
Amortization0.12 Cr0.08 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.